Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-25-067508
Filing Date
2025-07-14
Accepted
2025-07-14 06:03:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10616
  Complete submission text file 0001104659-25-067508.txt   12468
Mailing Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085
Business Address NO. 39 SHANGDI XI ROAD HAIDIAN DISTRICT BEIJING F4 100085 86-10-82890088
SINOVAC BIOTECH LTD (Subject) CIK: 0001084201 (see all company filings)

EIN.: 000000000 | State of Incorp.: B9 | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-79318 | Film No.: 251120062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SAIF PARTNERS, 2 PACIFIC PL., STE. 2115 88 QUEENSWAY HONG KONG K3 00000
Business Address SAIF PARTNERS, 2 PACIFIC PL., STE. 2115 88 QUEENSWAY HONG KONG K3 00000 852-2918-2205
SAIF Partners IV L.P. (Filed by) CIK: 0001472789 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: SCHEDULE 13D/A